ETON: Eton Pharmaceuticals Inc

ETON新闻

• 12:44 Eton Pharmaceuticals获得血管瘤药物美国销售权
• 12:41 Eton Pharmaceuticals acquires U.S. rights to hemangioma drug
• 18:54 DESMODA口服溶液获FDA批准用于治疗尿崩症
• 18:53 DESMODA oral solution receives FDA approval for diabetes insipidus
• 16:17 伊顿制药获超罕见病药物许可后股价上涨
• 16:17 Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug
• 12:02 伊顿制药获得超罕见病治疗候选药物的许可
• 12:01 Eton Pharmaceuticals licenses ultra-rare disease treatment candidate
• 20:28 Implied Volatility Surging for Eton Pharmaceuticals Stock Options
• 22:35 Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
• 22:21 Eton Pharmaceuticals Q3 每股收益 逊于预期, 营收 超出预期
• 22:21 Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates
• 19:01 Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
• 03:05 Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold
• 21:18 Monopar Therapeutics: A Healthy Dose Of Skepticism Warranted (NASDAQ:MNPR)
• 09:06 Ero Copper Leads 10 Hot Stocks Onto IBD Lists. Build Your Watchlist With These Screens
• 08:51 Micron Leads 9 Hot Stocks Onto Best Stock Lists: Check Out Who's In The IBD 50, Big Cap 20, More
• 08:57 Broadcom, Taiwan Semi, Other Tech Standouts Rule IBD Stock Lists: See New Names On IBD 50, Big Cap Leaders, Stock Spotlight And More
• 16:57 Implied Volatility Surging for Eton Pharmaceuticals Stock Options
• 22:10 Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
• 22:06 Eton (ETON) Q2 Revenue Jumps 108%
• 14:00 Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
• 11:01 FDA accepts Eton’s NDA for ET-600 desmopressin oral solution
• 10:55 Eton Pharmaceuticals to join Russell 2000 and 3000 indexes